Ticker
CUECompany Name
CUE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Gross Profit | Gross Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 8.29M | 100% | $ 8.29M |
3/31/2025 | $ 7.99M | 100% | $ 7.99M |
12/31/2024 | $ 9.29M | 100% | $ 9.29M |
9/30/2024 | $ 9.53M | 100% | $ 9.53M |
6/30/2024 | $ 8.3M | 100% | $ 8.3M |
3/31/2024 | $ 7.02M | 100% | $ 7.02M |
12/31/2023 | $ 5.49M | 100% | $ 5.49M |
9/30/2023 | $ 3.82M | 100% | $ 3.82M |
6/30/2023 | $ 1.79M | 100% | $ 1.79M |
3/31/2023 | $ 432.23K | 100% | $ 432.23K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Revenues
(=) Gross %
Gross % for CUE BIOPHARMA INC is calculated as follows: GP [ $ 3.73M ] / Revenues [ $ 3.73M ]
(=) Gross % [ 100% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.8K |
---|---|
min | -72.25% |
max | 150.26% |
average | 53.13% |
median | 49.48% |
std | 31.57% |